These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 10440436)

  • 101. AIDS patients with bacterial lower respiratory tract infections: treatment with ofloxacin versus sulbactam-ampicillin.
    De Simone C; Trinchieri V; Tzantzoglou S; Famularo G; Moretti S; Delia S
    J Chemother; 1992 Dec; 4(6):376-80. PubMed ID: 1287139
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Randomized comparative trial with ampicillin/sulbactam versus cefamandole in the therapy of community acquired pneumonia.
    Williams D; Perri M; Zervos MJ
    Eur J Clin Microbiol Infect Dis; 1994 Apr; 13(4):293-8. PubMed ID: 8070432
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Sulbactam/ampicillin in the treatment of pediatric infections.
    Kanra G; Secmeer G; Akalin E; Ecevit Z; Calikoglu AS; Gunel M; Tarim O
    Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):185S-187S. PubMed ID: 2591177
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Treatment of intracranial abscesses: experience with sulbactam/ampicillin.
    Akova M; Akalìn HE; Korten V; Ozgen T; Erbengi A
    J Chemother; 1993 Jun; 5(3):181-5. PubMed ID: 8371128
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Comparative efficacy of cefixime and ampicillin-sulbactam in shigellosis in children.
    Helvaci M; Bektaşlar D; Ozkaya B; Yaprak I; Umurtak B; Ertuğrul A
    Acta Paediatr Jpn; 1998 Apr; 40(2):131-4. PubMed ID: 9581302
    [TBL] [Abstract][Full Text] [Related]  

  • 106. A prospective, multi centre, randomized clinical study to compare the efficacy and safety of Ertapenem 3 days versus Ampicillin-Sulbactam 3 days in the treatment of localized community acquired intra-abdominal infection. (T.E.A. Study: Three days Ertapenem vs three days Ampicillin-sulbactam).
    Coccolini F; Catena F; Ansaloni L; Ercolani G; Di Saverio S; Gazzotti F; Lazzareschi D; Pinna AD
    BMC Gastroenterol; 2011 Apr; 11():42. PubMed ID: 21501482
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Comparative evaluation of efficacy and safety of cefotaxime-sulbactam with amoxicillin-clavulanic acid in children with lower respiratory tract infections.
    Pareek A; Kulkarni M; Daga S; Deshpande A; Chandurkar N
    Expert Opin Pharmacother; 2008 Nov; 9(16):2751-7. PubMed ID: 18937610
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Use of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients.
    Grayson ML; Gibbons GW; Habershaw GM; Freeman DV; Pomposelli FB; Rosenblum BI; Levin E; Karchmer AW
    Clin Infect Dis; 1994 May; 18(5):683-93. PubMed ID: 8075257
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Use of ampicillin/sulbactam (sultamicillin) in the management of pediatric infections. Introduction.
    Arredondo-García JL
    Pediatr Infect Dis J; 1998 Mar; 17(3 Suppl):S3. PubMed ID: 9519906
    [No Abstract]   [Full Text] [Related]  

  • 110. Sulbactam plus ampicillin: interim review of efficacy and safety for therapeutic and prophylactic use.
    Lees L; Milson JA; Knirsch AK; Greenhalgh K
    Rev Infect Dis; 1986; 8 Suppl 5():S644-50. PubMed ID: 3026019
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Comparison of ampicillin/sulbactam versus clindamycin in the prevention of infection in patients undergoing head and neck surgery.
    Johnson JT; Kachman K; Wagner RL; Myers EN
    Head Neck; 1997 Aug; 19(5):367-71. PubMed ID: 9243262
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Empiric use of cefepime in the treatment of lower respiratory tract infections in children.
    Bradley JS; Arrieta A
    Pediatr Infect Dis J; 2001 Mar; 20(3):343-9. PubMed ID: 11303848
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Comparison of ampicillin/sulbactam plus aminoglycoside vs. ampicillin plus clindamycin plus aminoglycoside in the treatment of intraabdominal infections in children. The Multicenter Group.
    Collins MD; Dajani AS; Kim KS; King DR; Kaplan SL; Azimi PH; Kolokathis A; Swanson R
    Pediatr Infect Dis J; 1998 Mar; 17(3 Suppl):S15-8; discussion S20-1. PubMed ID: 9519910
    [No Abstract]   [Full Text] [Related]  

  • 114. Efficacy and safety of Sultamicillin (Ampicillin/Sulbactan) and Amoxicillin/Clavulanic acid in the treatment of upper respiratory tract infections in adults--an open-label, multicentric, randomized trial.
    Ferreira JB; Rapoport PB; Sakano E; Kós AO; Piltcher OB; Pignatari SS; Pinheiro SD; Mocellin M
    Braz J Otorhinolaryngol; 2006; 72(1):104-11. PubMed ID: 16917560
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Treatment of acute pelvic inflammatory disease in the ambulatory setting: trial of cefoxitin and doxycycline versus ampicillin-sulbactam.
    Kosseim M; Ronald A; Plummer FA; D'Costa L; Brunham RC
    Antimicrob Agents Chemother; 1991 Aug; 35(8):1651-6. PubMed ID: 1929337
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Cefuroxime therapy for pneumonia in infants and children.
    Nelson JD; Kusmiesz H; Shelton S
    Pediatr Infect Dis; 1982; 1(3):159-63. PubMed ID: 6755404
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Risk factors leading to clinical failure in the treatment of intra-abdominal or skin/soft tissue infections.
    Falagas ME; Barefoot L; Griffith J; Ruthazar R; Snydman DR
    Eur J Clin Microbiol Infect Dis; 1996 Dec; 15(12):913-21. PubMed ID: 9031873
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Ampicillin-sulbactam vs clindamycin in head and neck oncologic surgery. The need for gram-negative coverage.
    Weber RS; Raad I; Frankenthaler R; Hankins P; Byers RM; Guillamondegui O; Wolf P; Smith T; Goepfert H
    Arch Otolaryngol Head Neck Surg; 1992 Nov; 118(11):1159-63. PubMed ID: 1418893
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Comparison of ampicillin-sulbactam regimens simulating 1.5- and 3.0-gram doses to humans in treatment of Escherichia coli bacteremia in mice.
    Lister PD; Sanders CC
    Antimicrob Agents Chemother; 1995 Apr; 39(4):930-6. PubMed ID: 7785998
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Meropenem versus cefuroxime plus gentamicin for treatment of serious infections in elderly patients.
    Jaspers CA; Kieft H; Speelberg B; Buiting A; van Marwijk Kooij M; Ruys GJ; Vincent HH; Vermeulen MC; Olink AG; Hoepelman IM
    Antimicrob Agents Chemother; 1998 May; 42(5):1233-8. PubMed ID: 9593156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.